跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL
Approved
THERAPEUTIC
MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL
MEDOCHEMIE LTD (FACTORY B -INJECTABLE FACILITY) (CYPRUS)ZHUHAI UNITED LABORATORIES CO, LTD. (intermediate 5:1 mixture) (CHINA)
🇸🇬 Health Sciences Authority
Approval Date
Jan 27, 2026
Approval ID
a38a2fbc6815a40c
Company
MEDOCHEMIE LTD (FACTORY B -INJECTABLE FACILITY) (CYPRUS)ZHUHAI UNITED LABORATORIES CO, LTD. (intermediate 5:1 mixture) (CHINA)
Type
Therapeutic
Approval Details
Approval Id
a38a2fbc6815a40c
Drug Name
MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL
Product Name
MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL
Approval Number
SIN17446P
Approval Date
2026-01-27
Registrant
MEDOCHEMIE SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 27, 2026
Approval ID
a38a2fbc6815a40c
Type
Therapeutic
Back to HSA Approvals